Evidence map›Paper›PMID 38520561›Full record

ArticleHuman genetics2024

Biallelic variants in GTF3C5, a regulator of RNA polymerase III-mediated transcription, cause a multisystem developmental disorder.

Aiko Iwata-Otsubo, Cara M Skraban, Atsunori Yoshimura, Toyonori Sakata, Cesar Augusto P Alves, Sarah K Fiordaliso, Yukiko Kuroda, Jaime Vengoechea, Angela Grochowsky, Paige Ernste and 11 more

Abstract read
In one paragraph

Article in Human genetics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Biallelic variants inBrain communications · 2025
    Article
  3. Biallelic variants in GTF3C3 result in an autosomal recessive disorder with intellectual disability.Genetics in medicine : official journal of the American College of Medical Genetics · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 6 institutions in 2 countries.

Aiko Iwata-OtsuboDivision of Human Genetics/Roberts Individualized Medical Genetics Center, Children's Hospital of Philadelphia, Philadelphia, PA, 19104, USA. aotsubo@med.umich.edu.
Cara M SkrabanDivision of Human Genetics/Roberts Individualized Medical Genetics Center, Children's Hospital of Philadelphia, Philadelphia, PA, 19104, USA.
Atsunori YoshimuraLaboratory of Genome Structure and Function, Institute for Quantitative Biosciences, The University of Tokyo, Tokyo, 113-0032, Japan.
Toyonori SakataLaboratory of Genome Structure and Function, Institute for Quantitative Biosciences, The University of Tokyo, Tokyo, 113-0032, Japan.
Cesar Augusto P AlvesDepartment of Radiology, Children's Hospital of Philadelphia, Philadelphia, PA, 19104, USA.
Sarah K FiordalisoDivision of Human Genetics/Roberts Individualized Medical Genetics Center, Children's Hospital of Philadelphia, Philadelphia, PA, 19104, USA.
Yukiko KurodaDivision of Human Genetics/Roberts Individualized Medical Genetics Center, Children's Hospital of Philadelphia, Philadelphia, PA, 19104, USA.
Jaime VengoecheaDepartment of Human Genetics, Emory University, Atlanta, GA, 30322, USA.
Angela GrochowskyDepartment of Pediatrics, Vanderbilt University Medical Center, Nashville, TN, 37232, USA.
Paige ErnsteDepartment of Pediatrics, Vanderbilt University Medical Center, Nashville, TN, 37232, USA.
Lauren LulisDivision of Genomic Diagnostics, Children's Hospital of Philadelphia, Philadelphia, PA, 19104, USA.
Addie NesbittDivision of Genomic Diagnostics, Children's Hospital of Philadelphia, Philadelphia, PA, 19104, USA.
Ahmad Abou TayounDivision of Genomic Diagnostics, Children's Hospital of Philadelphia, Philadelphia, PA, 19104, USA.
Christopher GrayDivision of Human Genetics/Roberts Individualized Medical Genetics Center, Children's Hospital of Philadelphia, Philadelphia, PA, 19104, USA.
Meghan C TowneAmbry Genetics, Aliso Viejo, CA, 92656, USA.
Kelly RadtkeAmbry Genetics, Aliso Viejo, CA, 92656, USA.
Elizabeth A NormandGeneDx, Gaithersburg, MD, 20877, USA.
Lindsay RhodesGeneDx, Gaithersburg, MD, 20877, USA.
Christoph SeilerZebrafish Core, The Children's Hospital of Philadelphia, Philadelphia, PA, 19104, USA.
Katsuhiko ShirahigeLaboratory of Genome Structure and Function, Institute for Quantitative Biosciences, The University of Tokyo, Tokyo, 113-0032, Japan.
Kosuke IzumiDivision of Human Genetics/Roberts Individualized Medical Genetics Center, Children's Hospital of Philadelphia, Philadelphia, PA, 19104, USA. Kosuke.Izumi@UTsouthwestern.edu.
Children's Hospital of Philadelphia · USThe University of Tokyo · JPAmbry Genetics (United States) · USVanderbilt University Medical Center · USEmory University · USUniversity of Pennsylvania · US

Funding

MEDICAL GENETICS RESEARCH TRAINING GRANTT32GM008638 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI Rebecca Ganetzky · 1997 to 2026
$8.7M
NIGMS NIH HHS T32 GM008638NIH HHS T32GM008638
6 · The paper itself

Abstract

General transcription factor IIIC subunit 5 (GTF3C5) encodes transcription factor IIIC63 (TFIIIC63). It binds to DNA to recruit another transcription factor, TFIIIB, and RNA polymerase III (Pol III) to mediate the transcription of small noncoding RNAs, such as tRNAs. Here, we report four individuals from three families presenting with a multisystem developmental disorder phenotype with biallelic variants in GTF3C5. The overlapping features include growth retardation, developmental delay, intellectual disability, dental anomalies, cerebellar malformations, delayed bone age, skeletal anomalies, and facial dysmorphism. Using lymphoblastoid cell lines (LCLs) from two affected individuals, we observed a reduction in TFIIIC63 protein levels compared to control LCLs. Genome binding of TFIIIC63 protein is also reduced in LCL from one of the affected individuals. Additionally, approximately 40% of Pol III binding regions exhibited reduction in the level of Pol III occupancy in the mutant genome relative to the control, while approximately 54% of target regions showed comparable levels of Pol III occupancy between the two, indicating partial impairment of Pol III occupancy in the mutant genome. Yeasts with subject-specific variants showed temperature sensitivity and impaired growth, supporting the notion that the identified variants have deleterious effects. gtf3c5 mutant zebrafish showed developmental defects, including a smaller body, head, and eyes. Taken together, our data show that GTF3C5 plays an important role in embryonic development, and that biallelic variants in this gene cause a multisystem developmental disorder. Our study adds GTF3C5-related disorder to the growing list of genetic disorders associated with Pol III transcription machinery.

Indexed as

Developmental DisabilitiesRNA Polymerase IIITranscription Factors, TFIIIAllelesAnimalsChildChild, PreschoolFemaleHumansIntellectual DisabilityMaleMutationPedigreePhenotypeTranscription Factors, TFIITranscription Factor TFIIICRNA Polymerase IIITranscription Factors, TFIITranscription Factors, TFIIITranscription Factor TFIIIC

Identifiers

PMID38520561
PMCPMC13502192
OpenAlexW4393115604

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.